Related by context. All words. (Click for frequent words.) 75 Vaccine Candidate 75 Respiratory Virus 74 Respiratory Syncytial Virus 73 Bacteremia 72 Enterobacter cloacae 72 Adjuvanted 72 Pandemic Flu Vaccine 72 Herpes Simplex Virus 72 bacterium Neisseria meningitidis 71 Cytomegalovirus 71 Escherichia coli Klebsiella pneumoniae 71 Streptococcus pneumonia 71 Epstein Barr Virus EBV 71 Immunotherapeutic 71 Cytomegalovirus CMV 71 Dengue Virus 71 Rotavirus Vaccine 71 Staphylococcal 71 serogroup B 70 varicella zoster virus VZV 70 Hepatitis B Virus 70 parainfluenza 70 Herpes Simplex 70 Inactivated 70 Adenoviral 70 Drug Resistant 70 Antibiotic Resistant 70 b Hib 70 Influenza Virus 70 rotaviruses 70 Therapeutic Vaccine 70 Bronchiolitis 70 Vaccine Shows Promise 70 Staphylococcus aureus infections 70 Endocarditis 70 Bordetella pertussis 70 Virus Infection 70 C. trachomatis 70 Hepatitis C Virus 69 Macrolide 69 MenB 69 Cryptococcus neoformans 69 Entry Inhibitor 69 methicillin susceptible Staphylococcus aureus 69 influenzae 69 virus HBV 69 Drug Shows Promise 69 Novel Vaccine 69 Multidrug resistant 69 Parainfluenza 69 Initiates Clinical 69 Chronic Sinusitis 69 Streptococcus pneumoniae pneumococcus 69 Fludase 69 Chronic Hepatitis B 69 Hepatitis B Vaccine 69 Entamoeba histolytica 69 Shows Promise Against 69 Multidrug Resistant 69 Atopic Dermatitis 69 Seasonal Influenza Vaccine 69 simplex virus 69 Monoclonal Antibody 69 Plasmid DNA 69 Parvovirus B# 69 Virus Vaccine 68 cytomegalovirus infection 68 hMPV 68 Treatment Shows Promise 68 Live Attenuated Influenza Vaccine 68 Antiviral Drug 68 Combination Vaccine 68 linezolid resistant 68 Vancomycin resistant 68 nonbacterial 68 BRSV 68 Papillomavirus 68 chlamydial infections 68 Thiovir 68 HCV Hepatitis C 68 Motavizumab 68 Investigational Treatment 68 virosome 68 Immune Responses 68 Respiratory syncytial virus 68 Lymphocytic 68 meningococcus 68 Vaccine Protects Against 68 Viral Infections 68 Adenovirus 68 orthopoxvirus 68 Streptococcal 68 Haemophilus influenza 68 H. Pylori 68 Fungal Infections 68 Helicobacter Pylori 68 abacavir Ziagen 68 Nosocomial 68 Mycobacterium tuberculosis TB 68 Initiates Clinical Trial 68 hemorrhagic fever viruses 68 Human Monoclonal Antibodies 68 Hepatitis B HBV 68 Chlamydia trachomatis 68 S.aureus 67 Progressive Multifocal Leukoencephalopathy 67 Alferon N 67 Immune Therapy 67 Achieves Primary Endpoint 67 Nanoemulsion 67 Streptococcus Pneumoniae 67 MenACWY 67 Prophylactic Treatment 67 Influenza Vaccine 67 Genital Herpes 67 Chagas Disease 67 Mycoplasma pneumoniae 67 bacterium Mycobacterium tuberculosis 67 Maribavir 67 Enterococcus faecium 67 herpes zoster shingles 67 Klebsiella pneumonia 67 Human Papillomavirus 67 cytomegalovirus retinitis 67 Histoplasmosis 67 Antifungal 67 MRSA Infections 67 Bloodstream Infections 67 Antibiotic resistant 67 respiratory syncytial virus 67 streptococcus pneumonia 67 G6PD deficiency 67 Avian Influenza Vaccine 67 IgM antibodies 67 Complicated Skin 67 valacyclovir Valtrex 67 Inflammatory Disease 67 Pandemic Influenza Vaccine 67 Inflammatory Markers 67 shingles herpes zoster 67 Hospital Acquired Pneumonia 67 B. cepacia 67 Streptococcus agalactiae 67 Combo Therapy 67 Bacterial Vaginosis 67 Phase 2b Clinical Trial 67 pertussis tetanus 67 Somatostatin 67 Begin Clinical Trials 67 immunosuppressed patients 67 Diarrheal 66 Monoclonal 66 Epstein Barr Virus 66 P aeruginosa 66 Lymphoid 66 nasal carriage 66 Streptococci 66 carbapenem resistant 66 acyclovir Zovirax 66 Resistant Staphylococcus Aureus 66 Acute Bacterial Sinusitis ABS 66 candidemia 66 viral respiratory infections 66 Successfully Completes Phase 66 Tuberculosis Vaccine 66 Efficacy Trial 66 Epidermal Growth Factor Receptor 66 bacteria Streptococcus pneumoniae 66 pneumococcal infection 66 Staphylococcus aureus MRSA 66 Staphylococcus epidermidis 66 Inflammatory Diseases 66 Vaccine Adjuvant 66 Meningococcal Disease 66 chlamydial 66 Fibroblast 66 TB Vaccine 66 Rimantadine 66 tuberculosis hepatitis B 66 Resistant Staph 66 Altastaph 66 Seasonal Influenza 66 Urinary Tract Infections 66 Proven Effective 66 Varicella zoster virus 66 Test Detects 66 nucleotide analog 66 Amgen Neulasta R 66 Salmonella typhi 66 Candidiasis 66 Infected Patients 66 Tyrosine Kinase Inhibitor 66 Phase 2b Trial 66 Epratuzumab 66 Candida infection 66 Treating Chronic 66 enterococcal 66 Advanced Melanoma 66 TTR amyloidosis 66 Monoclonal Antibodies 66 Haemophilus b Conjugate 66 Dendritic Cells 66 Conjugate Vaccine 66 Begins Dosing 66 Allergic Rhinitis 66 Immunoglobulin 66 Initiates Phase II 66 Single Dose 66 Shigella bacteria 66 herpesviruses 66 Chronic Prostatitis 66 Helicobacter pylori H. pylori 66 Meets Primary Endpoint 66 Cytotoxic 66 GABHS 66 Fabry Disease 66 Antibacterials 66 Pseudomonas aeruginosa infections 66 Thromboembolism 66 Respiratory Infections 66 HQK 66 Initiates Dosing 66 FDA Clears 66 Prostate Cancer Vaccine 66 Hepatitis C Virus HCV 66 Improves Outcomes 66 Nasal Powder 66 Flavivirus 66 invasive candidiasis 66 Interferon Beta 66 Novel Therapeutic 66 Antiviral Drugs 65 fluconazole resistant 65 Ribavirin causes 65 bacterial respiratory infections 65 Naive Patients 65 Molecular Diagnostic 65 Measles mumps 65 recombinant hepatitis B 65 Diptheria 65 Opportunistic infections 65 Trichomonas vaginalis 65 monoclonal antibody MAb 65 parainfluenza viruses 65 Methicillin Resistant 65 cryptococcosis 65 Prolongs Survival 65 Neugene 65 Poliovirus 65 Malaria Vaccine 65 Bordetella 65 Stanate R 65 Transdermal Patch 65 Keratitis 65 replicon 65 Malignant Melanoma 65 respiratory viral infections 65 Oncolytic 65 H. influenzae 65 fluoroquinolone resistance 65 methicillin resistant MRSA 65 Pancreas Cancer Vaccine 65 Bloodstream infections 65 Diabetic Foot Ulcer 65 Anaplasma 65 Clostridium difficile Infection 65 KL4 Surfactant 65 Haemophilus 65 human metapneumovirus 65 asymptomatic carriers 65 NS#/#A protease 65 vaginal candidiasis 65 P. falciparum malaria 65 Epstein Barr virus EBV 65 Bacterial Infections 65 toxoid 65 Pneumococcus 65 immuno suppressed 65 Streptococcus pyogenes 65 CDC Recommends 65 ChronVac C R 65 Herpes zoster 65 Virus HIV 65 Transdermal Delivery 65 prevent rotavirus gastroenteritis 65 Leukemias 65 FDA Approvals 65 Vancomycin Resistant 65 Demonstrates Efficacy 65 Myelodysplastic Syndrome MDS 65 Anticoagulant 65 latent tuberculosis TB 65 Tumor Necrosis Factor 65 Human Papilloma 65 PPSV# 65 Human cl 65 Genital Warts 65 Tamiflu Relenza 65 SPRYCEL ® 65 Viral Infection 65 anogenital warts 65 hypereosinophilic syndrome 65 Experimental Vaccine 65 Diabetic Neuropathy 65 Avian Flu Vaccine 65 Antitumor 65 pneumococci 65 Ebola Vaccine 65 Neisseria gonorrhoeae 65 Develop Novel 65 Shows Promising 65 Neisseria meningitides 65 shiga toxin 65 Human Monoclonal Antibody 65 Chronic Hepatitis 65 Intravenous Formulation 65 amebiasis 65 Lupus Nephritis 65 Noxafil 65 HPV Human Papilloma 65 Chlamydia pneumoniae 65 Aliskiren 65 Factor VIIa 65 pyogenes 65 rhinotracheitis 65 Infectivity 65 Exacerbation 65 Rotavirus Vaccines 65 Drug Candidate 65 chickenpox varicella 65 Pneumococcal Conjugate Vaccine 65 parainfluenza virus 65 Intranasal 65 Haemophilus influenza type 65 penicillin resistant Streptococcus 65 Severe Sepsis 65 metastatic neuroendocrine tumors 65 Foodborne 65 Lupus Drug 65 Non Invasive Treatment 65 RNAi Therapeutic 65 Streptococcus pneumoniae Haemophilus influenzae 65 Pegylated Interferon 65 Intravenous immunoglobulin 65 Haemophilus influenzae 65 Varicella Zoster 65 highly pathogenic influenza 65 acellular pertussis DTaP 65 ChronVac C 65 human rhinovirus HRV 65 Smallpox Vaccine 65 TransVax ™ 65 Therapeutic Antibody 65 Systemic Delivery 65 Pneumococcal Vaccine 65 IND Application 65 Viral Load 65 Completes Patient Enrollment 65 H#N# Swine Influenza 65 thalidomide Thalomid 65 Pemphigus 65 epiglottitis 65 Tigecycline 65 Telbivudine 65 polysaccharide vaccine 65 Herpes Zoster 65 Candida species 65 cidofovir 65 Asthma COPD 64 oral prodrug 64 Lung Injury 64 Potentially Fatal 64 Bacterial Infection 64 Nitazoxanide 64 Bronchopulmonary Dysplasia 64 Methicillin resistant S. aureus 64 Angioedema 64 Successfully Treated 64 Moraxella catarrhalis 64 Assay Kits 64 ergot derivatives 64 systemic fungal infections 64 VZV 64 Chlamydia psittaci 64 Vesivirus 64 tetanus diphtheria vaccines 64 DepoCyt 64 SinoFresh TM 64 bacterial parasitic 64 influenza antiviral medications 64 Hepatitis C Viral 64 Anticonvulsant 64 Vicriviroc 64 chronic granulomatous disease 64 M. catarrhalis 64 Bronchodilator 64 lucinactant 64 Community Acquired Pneumonia 64 Immunologic 64 Receives Orphan Drug Designation 64 tickborne 64 Blood Pressure Drug 64 Phase IIa Clinical Trial 64 Fibrinogen 64 Malignant Glioma 64 live attenuated influenza 64 Antitumor Activity 64 Premature Infants 64 murine leukemia virus 64 Flu Virus 64 Human papilloma virus 64 thiazolides 64 Escherichia coli O# 64 reverse vaccinology 64 Humanized Anti 64 K. pneumoniae 64 Staphylococcus aureus S. aureus 64 lupus anticoagulant 64 HIV treatments Reyataz 64 MRSA Clostridium difficile 64 Chronic Lung 64 Patients Receiving 64 HBV HCV 64 Hemophilia B 64 Etravirine 64 Polyneuropathy 64 metastatic malignant 64 antibiotic resistant bacterial infections 64 FDA Okays 64 H Pylori 64 Juvenile Idiopathic Arthritis JIA 64 humanized monoclonal 64 Aspergillosis 64 HIV coinfected 64 Cervical Dysplasia 64 PEDIARIX 64 Associated Diarrhea 64 Severe Asthma 64 serologic testing 64 Mucosal 64 Babesia 64 Anaplasmosis 64 Pediatric Patients 64 NNRTI resistant virus 64 parvovirus B# 64 chronic eosinophilic leukemia 64 Prodarsan R 64 valent pneumococcal conjugate vaccine 64 Nicotine Vaccine 64 vaccine LAIV 64 Dasatinib 64 Avian Flu Virus 64 Latent TB 64 neuro developmental disorders 64 viral subtypes 64 Acidosis 64 macrolide resistant 64 Herpes Virus 64 hypocalcaemia 64 Tumor Targeting 64 gonococcal 64 Esophagitis 64 Ventilator Associated 64 polio measles mumps 64 Novel Oral 64 helicobacter pylori 64 oncolytic virus therapies 64 Anthrax Toxin 64 Shigatoxin producing E. coli 64 Genetic Mutation 64 Rapid Detection 64 CYT# potent vascular disrupting 64 Invasive Pneumococcal Disease 64 Initiates Enrollment 64 vaginal lesions 64 diphtheria pertussis whooping cough 64 LAB CGRP 64 Retrovirus 64 Twinrix 64 kidney urologic 64 Serologic 64 Hepatitis C HCV 64 QuickVue R 64 Therapeutic Vaccines 64 Recombinant interferon alpha 64 hemorrhagic cystitis 64 Diagnostic Tests 64 MKC# MT 64 Staphylococcus Aureus 64 Otitis Media 64 Respiratory syncytial virus RSV 64 Human papillomavirus 64 Nonalcoholic fatty liver 64 Autoantibodies 64 genital herpes infections 64 Coxsackie virus 64 Metastatic Melanoma 64 Coronavirus 64 Protease Inhibitors 64 Skin Structure Infections 64 cepacia 64 Interferon Alpha 64 immunopathology 64 cSSSIs 64 ATG Fresenius S 64 cytomegalovirus CMV 64 Anthracycline 64 rhinovirus infections 64 Molluscum 64 Chronic Rhinosinusitis 64 induces antibodies 64 bacterium Streptococcus 64 Hib meningitis 64 Oral Insulin 64 Therapeutic Antibodies 64 Subtype 64 Kinase Inhibitor 64 Monoclonal antibody 64 Hepatocellular Carcinoma 64 Nosocomial Pneumonia 64 Streptococcus pneumoniae serotypes 64 Mimetics 64 Replacement Therapy 64 Burkholderia pseudomallei 64 refractory gout 64 atypical hemolytic uremic syndrome 64 Drug Combo 64 tetracycline antibiotic 64 quadrivalent human papillomavirus 64 Catheter Associated 64 rhinovirus infection 64 sodium stibogluconate 64 Universal Influenza Vaccine 64 orchitis 64 Myocarditis 64 HIV HCV coinfected 64 Idiopathic Pulmonary Fibrosis 64 Diastolic Heart Failure 64 Kinase Inhibitors 64 Aganocide 64 Inactivation 64 Hemorrhagic 64 Pafuramidine 64 conjugate vaccines 64 adeno associated viruses 64 vaccine Menveo 64 parasite Trypanosoma cruzi 64 Invasive pneumococcal disease 64 Septic Shock 64 neuraminidase inhibitor 64 Allogeneic 64 pneumococcal infections 64 plague bacterium Yersinia 64 Aviptadil 64 acute respiratory tract infections 64 multivalent vaccine 63 Atypical Hemolytic Uremic Syndrome 63 contagious bacterial infection 63 Omalizumab 63 trichomonas 63 S. aureus isolates 63 Daptomycin 63 Drug Prevents 63 Immune Cells 63 Files IND 63 Respiratory Distress 63 Ligand Epitope Antigen Presentation 63 H5 N1 63 Enteritidis 63 Pasteurella multocida 63 Chronic Myeloid Leukemia 63 Reports Preclinical Data 63 Gets FDA Clearance 63 N. meningitidis 63 TNF Blockers 63 Cholesterol Lowering Drug 63 Hemolytic 63 Epitopes 63 oseltamivir resistant 63 Bronchiectasis 63 tetanus polio 63 Multiple Sclerosis Rheumatoid Arthritis 63 CMV infection 63 Herpes simplex virus 63 severe malignant osteopetrosis 63 Mutation Analysis 63 Vaginal Gel 63 Intercell vaccine 63 Idiopathic Thrombocytopenic Purpura ITP 63 oral rotavirus vaccine 63 investigational integrase inhibitor 63 HPV-#/# 63 Ear Infections 63 Immune Mediated 63 recurrent genital herpes 63 See CLINICAL PHARMACOLOGY 63 Toxoid 63 BARACLUDE ® 63 treat chronic sinusitis 63 Ebola Virus 63 Candida infections 63 Disease Progression 63 F. tularensis 63 Thromboembolic 63 Develops Novel 63 Rheumatoid Arthritis Drug 63 S OIV 63 MenC 63 Safinamide 63 clade B 63 Th2 cytokines 63 Novel Mechanism 63 ESBL producing E. coli 63 varicella infection 63 Varicella 63 Vitro Activity 63 attach auristatin 63 Juvenile Idiopathic Arthritis 63 soluble tumor necrosis 63 CTAP# 63 Valopicitabine 63 inactivated poliovirus 63 Tetanus Toxoids 63 Methicillin 63 Hematopoietic 63 GlaxoSmithKline Plc Relenza 63 Serious Infections 63 Pseudomonas aeruginosa bacterium 63 pestis 63 C conjugate vaccine 63 Adefovir 63 anti infective treatments 63 Successfully Treats 63 E. faecalis 63 enterocolitis 63 Merck Suspends Lobbying 63 MVA nef 63 allergic airway 63 Presents Preclinical Data 63 C. perfringens 63 multiple sclerosis lupus 63 Elotuzumab 63 Chronic Myelogenous Leukemia 63 serotype #A 63 Mucositis 63 postexposure prophylaxis 63 capsular polysaccharide 63 Darapladib 63 Autoimmune Diseases 63 Proves Effective 63 Nucleoside 63 induce orthostatic hypotension 63 Subtypes 63 Non Alcoholic Fatty 63 Enteroviruses 63 Cardiotoxicity 63 diarrhea predominant irritable 63 ROTARIX 63 Enteric 63 subcutaneous immunoglobulin 63 Mouse Model 63 SIMPONI ® 63 Growth Hormone Deficiency 63 combination antiretroviral therapy 63 Unresectable 63 S. pneumoniae 63 Therapy Shows Promise 63 Hepatic Encephalopathy 63 meningococcal serogroup B 63 overactive bladder syndrome 63 Recombinant Human 63 sepsis meningitis 63 measles mumps rubella varicella 63 Phenylketonuria PKU 63 Clinical Outcome 63 JAK2 Inhibitor 63 include Healive 63 radezolid 63 Human papillomavirus HPV 63 Anticancer Agent 63 Inhaled Nitric Oxide 63 Clostridium difficile infections 63 Novel Antibiotic 63 Comvax 63 Shows Efficacy 63 Microneedles 63 fungal bacterial 63 INS# [001] 63 Initiate Clinical Trial 63 Universal Flu Vaccine 63 Ankara MVA 63 HCV Protease Inhibitor 63 Cytotoxicity 63 Varicella chicken pox 63 Streptococcus equi 63 mycobacterium tuberculosis 63 acetonide FA 63 Epitope 63 Aeromonas 63 Metabolic Disorder 63 Combination Treatment 63 chronic HBV 63 Demonstrates Significant 63 Nebulized 63 Antibody Discovery 63 bacterial sinusitis 63 Potent Antiviral Activity 63 fluoroquinolone resistant 63 Bilive R combined 63 gastrointestinal stromal tumors GISTs 63 Epilepsy Drug 63 Squamous 63 hypervirulent strain 63 inhibitory antibodies 63 Unvaccinated 63 Interferon gamma 63 Serotype 63 oropharyngeal candidiasis OPC 63 Invasive Fungal Infections 63 metapneumovirus 63 Dehydrogenase 63 Susceptibility Testing 63 Genetic Variation 63 herpes labialis 63 neuroendocrine cancers 63 vesicular stomatitis virus 63 pseudomembranous colitis 63 Parnate 63 Integrase Inhibitor 63 von Hippel Lindau 63 Neisseria meningitidis 63 human immunodeficiency 63 Faropenem 63 Protein Linked 63 P. ovale 63 neuronal nicotinic receptor NNR 63 included exfoliative dermatitis 63 virus RSV 63 carbapenem 63 investigational monoclonal antibody 63 noninfectious 63 toenail onychomycosis 63 bacterial pneumonias 63 Chronic Hepatitis C 63 Pooled Analysis 63 Antiviral Therapy 63 IIa Clinical Trial 63 tetanus pertussis 63 surface antigen HBsAg 63 Enterococci 63 Liver Injury 63 Sapacitabine 63 Interferon Gamma 63 Adenoviruses usually cause 63 RSV infections 63 Drug Combinations 63 posterior uveitis 63 Guidelines Issued 63 SIMPONI TM 63 Genes Linked 63 Osteoporosis Treatment 63 immune reconstitution syndrome 63 Enterobacter 63 bacteria Neisseria meningitidis 63 ALI ARDS 63 Premature Aging 63 Metastases 63 Strep 63 herpes simplex viruses 63 antibody MAb 63 pulmonary fungal infections 63 macrolide resistance 63 Demonstrates Positive 63 gastroenteritis conjunctivitis 63 idiopathic thrombocytopenic purpura ITP 63 Anti Tumor 63 Genes Identified 63 H#N# Influenza Vaccine 63 Shown Effective 63 Alinia 63 Vaccine Diphtheria CRM# Protein 63 Irritable Bowel 63 C. pneumoniae 63 Metabolic Disease 63 Sustiva efavirenz 63 chronic Hepatitis B 63 Gene Linked 63 influenza VLP vaccine 63 CMV vaccine 63 G CSFs 63 Morquio 63 poliovirus vaccine 63 interstitial cystitis IC 63 infection sinusitis 63 Mg Uk 63 Recombinant Protein 63 Conjugate 63 Eosinophilic 63 Janus kinase 63 corticosteroid dexamethasone 63 Hiberix 63 S aureus 63 discontinued Viread 63 NASH Huntington 63 Fluzone Intradermal 63 Angiotensin Converting Enzyme 63 post surgical adhesions 63 Cyclosporin 62 FDA APPROVES 62 Protease Inhibitor 62 complement inhibitor eculizumab 62 Acute otitis media 62 Phase 2a Trial 62 Ramoplanin 62 Inhalable 62 Improves Survival 62 Respiratory Viruses 62 Demonstrates Potent 62 Intercell Japanese Encephalitis 62 Hib vaccines 62 oral thrush 62 Skin Structure Infections ABSSSI 62 uricase 62 Human Papilloma Virus 62 Gout Drug 62 Neisseria 62 Omacetaxine 62 Adjuvant Chemotherapy 62 molecular diagnostic assay 62 HBV vaccine 62 acting neuraminidase inhibitor 62 Ehrlichia 62 Anidulafungin 62 Herpes virus 62 B Anflu R 62 PRN FDA Approves 62 Immunogenicity 62 Chronic Heart Failure 62 Immunocompromised 62 MRSA Staph 62 A1PI 62 FLU v 62 Measles Mumps 62 Myocardial Perfusion Imaging 62 multidrug resistant strains 62 SNT-MC#/idebenone 62 Rheumatoid 62 Aptamer 62 Iron Overload 62 Adjunctive 62 quinolone resistant 62 M2e 62 Immunosuppressant 62 chancroid 62 Vitrasert R 62 multiresistant 62 pneumonia tetanus 62 Gene Mutation 62 Oral Interferon 62 Enlarged Prostate 62 SARS Virus 62 opportunistic pathogens 62 Reduces Mortality 62 Eculizumab 62 First Patient Dosed 62 Synthetic Peptide 62 pharyngitis tonsillitis 62 biologic therapeutics 62 LCMV infection 62 rifamycins 62 Topical Treatment 62 Soft Tissue Sarcoma 62 Protein Interactions 62 Pegylated 62 molluscum contagiosum 62 Liprotamase 62 Psoriasis Drug 62 Polysaccharide Diphtheria Toxoid Conjugate 62 Cethromycin 62 Hemorrhagic Fever 62 CMV infections 62 Cancidas 62 Pulmonary Arterial Hypertension 62 Efficacious 62 ESBLs 62 chemotherapy induced neutropenia 62 Escherichia Coli 62 B. fragilis 62 Signaling Pathway 62 vancomycin resistant 62 administered concomitantly 62 Treatment Reduces 62 Antifungals 62 enteroviral 62 Sinus Infections 62 Inhibitory 62 infectious diseases autoimmune diseases 62 Actinic Keratosis 62 HIV1 62 Cytotoxic T 62 Babesiosis 62 Pneumococcal pneumonia 62 Beta Blocker 62 hyperphenylalaninemia HPA due 62 CholeraGarde R 62 disease CDAD 62 live attenuated vaccines 62 H5 H7 62 Retinopathy 62 whooping cough pertussis 62 Chemotherapeutic 62 Onychomycosis 62 denileukin diftitox 62 Colorectal Adenomas 62 Peginterferon 62 Denufosol 62 anti CD3 monoclonal 62 RiVax 62 lysosomal storage disease 62 Francisella 62 Silodosin 62 Acute Renal Failure 62 Acute Radiation Syndrome ARS 62 Vaccine Adjuvants 62 serogroup 62 Phase IIb Trial 62 coagulase negative staphylococci 62 haemolytic uraemic syndrome 62 S. aureus bloodstream infections 62 Phenotypes 62 Methicillin Resistant Staphylococcus aureus 62 griseofulvin 62 IgG antibody 62 Potent Inhibitor 62 tetravalent vaccine 62 RNAi Therapeutics 62 Pneumocystis carinii pneumonia 62 Oral Mucositis 62 nontuberculous mycobacteria 62 ara C 62 acute porphyria 62 Tetanus Diphtheria 62 Genotyping Test 62 nosocomial pneumonia 62 paratuberculosis 62 CYT# NicQb 62 Patients Treated With 62 STELARA TM 62 Attenuated 62 ACE Inhibitors 62 amantadine Symmetrel 62 Factor Receptor 62 attenuated strain 62 Myelofibrosis 62 Malignancies 62 S. aureus infections 62 Initiates Phase III 62 Influenza Type 62 Bilive TM combined 62 hepatitis B infection 62 Staphylococci 62 HPV Human Papillomavirus 62 Systemic lupus erythematosus 62 COPEGUS R 62 Quadrivalent 62 Coxsackievirus 62 M. paratuberculosis 62 botulinum neurotoxin 62 protein tyrosine phosphatase 1B 62 Polymerase Inhibitor 62 diarrhea abdominal cramps nausea 62 Chronic HCV 62 genital human papillomavirus 62 FluCAM arm 62 sulfamethoxazole 62 gastro intestinal inflammation 62 respiratory pathogens 62 Benign Prostatic Hyperplasia 62 inflammatory demyelinating 62 trimethoprim sulfamethoxazole 62 Clinical Trial Results 62 cervical cancer genital warts 62 urogenital infections 62 Antimalarial 62 Slow Progression 62 RSV replication 62 FDA Approves Drug 62 PCV1 62 Th1 type 62 adalimumab Humira 62 itraconazole Sporanox 62 NRTI resistance 62 Fluvastatin 62 conserved antigens NP 62 TNF Tumor Necrosis Factor 62 Vitrasert ® 62 GelVac TM 62 Autoimmune Disorders 62 Initiates Clinical Trials